Specialty Oncology
-
{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Talazoparib in Advanced Breast Cancer With a Germline BRCA Mutation
{{ evaluation.question.text }}{{choice.text}}{{evaluation.answerSet[0].text}}Test Code: OT0219PHPublished: April 2019Expires: 9/13/2025Sources: Allied Health CollectionDetailsRequired Passing Score: 8/10 (80%)